Literature DB >> 27009390

Chemotherapy: Preventing competitive release.

Sarah Seton-Rogers.   

Abstract

Year:  2016        PMID： 27009390     DOI： 10.1038/nrc.2016.28

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.

Authors:  Pedro M Enriquez-Navas; Yoonseok Kam; Tuhin Das; Sabrina Hassan; Ariosto Silva; Parastou Foroutan; Epifanio Ruiz; Gary Martinez; Susan Minton; Robert J Gillies; Robert A Gatenby
Journal:  Sci Transl Med       Date:  2016-02-24       Impact factor: 17.956
  1 in total
  8 in total

1.  Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies.

Authors:  Aaron N Hata; Harald Paganetti; Clemens Grassberger; David McClatchy; Changran Geng; Sophia C Kamran; Florian Fintelmann; Yosef E Maruvka; Zofia Piotrowska; Henning Willers; Lecia V Sequist
Journal:  Cancer Res       Date:  2019-05-21       Impact factor: 12.701

Review 2.  Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance.

Authors:  Sruthi Sritharan; Sampurna Guha; Snoopy Hazarika; Nageswaran Sivalingam
Journal:  Apoptosis       Date:  2022-06-18       Impact factor: 5.561

Review 3.  Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance.

Authors:  Kyoung Ah Kang; Jin Won Hyun
Journal:  Toxicol Res       Date:  2017-01-15

Review 4.  MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.

Authors:  Ilaria Plantamura; Giulia Cosentino; Alessandra Cataldo
Journal:  Front Oncol       Date:  2018-09-03       Impact factor: 6.244

5.  miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2.

Authors:  Elif Değerli; Vildan Torun; Demet Cansaran-Duman
Journal:  Biol Res       Date:  2020-05-04       Impact factor: 5.612

6.  Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis.

Authors:  Hongwen Cao; Dan Wang; Peng Sun; Lei Chen; Yigeng Feng; Renjie Gao
Journal:  Aging (Albany NY)       Date:  2021-10-06       Impact factor: 5.682

7.  Computational Indicator Approach for Assessment of Nanotoxicity of Two-Dimensional Nanomaterials.

Authors:  Alexey A Tsukanov; Boris Turk; Olga Vasiljeva; Sergey G Psakhie
Journal:  Nanomaterials (Basel)       Date:  2022-02-15       Impact factor: 5.076

8.  The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer.

Authors:  Gong Chen; Qiong Chen; Fanxu Zeng; Liang Zeng; Haiyan Yang; Yi Xiong; Chunhua Zhou; Li Liu; Wenjuan Jiang; Nong Yang; Yongchang Zhang
Journal:  Oncotarget       Date:  2017-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.